KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Debt Ratio (2016 - 2026)

Emergent BioSolutions has reported Debt Ratio over the past 17 years, most recently at 0.43 for Q1 2026.

  • For Q1 2026, Debt Ratio fell 6.94% year-over-year to 0.43; the TTM value through Mar 2026 reached 0.43, down 6.94%, while the annual FY2025 figure was 0.43, 9.15% down from the prior year.
  • Debt Ratio for Q1 2026 was 0.43 at Emergent BioSolutions, roughly flat from 0.43 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.48 in Q4 2024 and troughed at 0.14 in Q4 2022.
  • A 5-year average of 0.33 and a median of 0.3 in 2024 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: tumbled 48.24% in 2022 and later skyrocketed 95.01% in 2024.
  • Year by year, Debt Ratio stood at 0.14 in 2022, then surged by 72.89% to 0.24 in 2023, then skyrocketed by 95.01% to 0.48 in 2024, then decreased by 9.15% to 0.43 in 2025, then rose by 0.13% to 0.43 in 2026.
  • Business Quant data shows Debt Ratio for EBS at 0.43 in Q1 2026, 0.43 in Q4 2025, and 0.45 in Q3 2025.